Vivos Therapeutics Revenue vs. Shares Owned by Institutions

VVOS -  USA Stock  

USD 2.48  0.20  8.77%

For Vivos Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vivos Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vivos Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vivos Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vivos Therapeutics over time as well as its relative position and ranking within its peers. Also, please take a look at World Market Map.

Vivos Current Profitability Trends 

 
Refresh
Is Vivos Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivos Therapeutics. If investors know Vivos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivos Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vivos Therapeutics is measured differently than its book value, which is the value of Vivos that is recorded on the company's balance sheet. Investors also form their own opinion of Vivos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vivos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivos Therapeutics' market value can be influenced by many factors that don't directly affect Vivos Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Vivos Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vivos Therapeutics Shares Owned by Institutions vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vivos Therapeutics's current stock value. Our valuation model uses many indicators to compare Vivos Therapeutics value to that of its competitors to determine the firm's financial worth.
Vivos Therapeutics is rated below average in revenue category among related companies. It is rated below average in shares owned by institutions category among related companies . The ratio of Revenue to Shares Owned by Institutions for Vivos Therapeutics is about  1,435,341 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vivos Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vivos Therapeutics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vivos Therapeutics' earnings, one of the primary drivers of an investment's value.

Vivos Revenue vs. Competition

Vivos Therapeutics is rated below average in revenue category among related companies. Market size based on revenue of Medical Devices industry is at this time estimated at about 120.93 Billion. Vivos Therapeutics adds roughly 14.54 Million in revenue claiming only tiny portion of all equities under Medical Devices industry.

Vivos Shares Owned by Institutions vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Vivos Therapeutics 
Revenue 
 = 
Money Received 
Discounts and Returns 
14.54 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Vivos Therapeutics 
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
10.13 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Vivos Shares Owned by Institutions Comparison

Vivos Therapeutics is currently under evaluation in shares owned by institutions category among related companies.

Vivos Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vivos Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vivos Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Vivos Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Vivos Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing, such as mild-to-moderate obstructive sleep apnea . Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado. Vivos Therapeutics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Vivos Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vivos Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vivos Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vivos Therapeutics' important profitability drivers and their relationship over time.

Use Vivos Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vivos Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Vivos Therapeutics Pair Trading

Vivos Therapeutics Pair Trading Analysis

Correlation analysis and pair trading evaluation for Vivos Therapeutics and Bio-Rad Laboratories. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Vivos Therapeutics position

In addition to having Vivos Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Thematic Idea Now

Consumer
Consumer Theme
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. Consumer theme has 40 constituents.
View All  Next Launch Consumer
Also, please take a look at World Market Map. Note that the Vivos Therapeutics information on this page should be used as a complementary analysis to other Vivos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Vivos Stock analysis

When running Vivos Therapeutics price analysis, check to measure Vivos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivos Therapeutics is operating at the current time. Most of Vivos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vivos Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vivos Therapeutics' price. Additionally, you may evaluate how the addition of Vivos Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
To fully project Vivos Therapeutics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vivos Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vivos Therapeutics' income statement, its balance sheet, and the statement of cash flows.
Potential Vivos Therapeutics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vivos Therapeutics investors may work on each financial statement separately, they are all related. The changes in Vivos Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vivos Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.